Abiomed Inc (ABMD) |
|
310.71 -4.27 (-1.36%)
|
08-07 15:05 |
|
Open: |
310.48 |
Pre. Close: |
314.98 |
|
High:
|
316.88 |
Low:
|
307.44 |
|
Volume:
|
304,973 |
Market Cap:
|
13,996M |
|
|
|
|
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
318.928 - 320.536 |
320.536 - 321.858 |
|
Low:
|
304.809 - 306.49 |
306.49 - 307.872 |
|
Close:
|
312.482 - 315.155 |
315.155 - 317.352 |
|
Technical analysis |
as of: 2020-08-07 2:23:35 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 372.81 One year: 435.45 |
| Support: |
Support1: 277.58 Support2: 251.86 |
| Resistance: |
Resistance1: 319.19 Resistance2: 372.81 |
| Pivot: |
301.58  |
| Moving Average: |
MA(5): 311.62 MA(20): 294.34
MA(100): 218.11 MA(250): 195.88 |
| MACD: |
MACD(12,26): 14.61 Signal(9): 14.33 |
| Stochastic oscillator: |
%K(14,3): 89.24 %D(3): 91.65 |
| RSI: |
RSI(14): 72.23 |
| 52-week: |
High: 319.19 Low: 119.01 Change(%): 63.0 |
| Average Vol(K): |
3-Month: 43166 10-Days: 32726 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ABMD has closed below upper band by 15.6%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 06 Aug 2020
Abiomed Inc (ABMD) Q1 2021 Earnings Call Transcript - Motley Fool
Thu, 06 Aug 2020
ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q1 - Yahoo Finance
Thu, 06 Aug 2020
Abiomed Inc. Q1 Earnings Fall - Nasdaq
Thu, 06 Aug 2020
Abiomed: Fiscal 1Q Earnings Snapshot | Business - Lincoln Journal Star
Thu, 06 Aug 2020
Abiomed Q1 21 Earnings Conference Call At 8:00 AM ET - Nasdaq
Thu, 06 Aug 2020
Abiomed Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin - Business Wire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: Nasdaq Global Select |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
45 |
| Shares Float (M) |
44 |
|
% Held by Insiders
|
2.04 |
|
% Held by Institutions
|
101.37 |
|
Shares Short (K)
|
2,460 |
|
Shares Short P. Month (K)
|
2,730 |
Stock Financials |
|
EPS
|
4.430 |
|
EPS Est This Year
|
2.330 |
|
EPS Est Next Year
|
2.670 |
|
Book Value (p.s.)
|
23.670 |
|
Profit Margin
|
24.14 |
|
Operating Margin
|
29.57 |
|
Return on Assets (ttm)
|
13.7 |
|
Return on Equity (ttm)
|
20.3 |
|
Qtrly Rev. Growth
|
-0.2 |
|
Gross Profit (p.s.)
|
15.310 |
|
Sales Per Share
|
18.670 |
|
EBITDA (p.s.)
|
5.974 |
|
Qtrly Earnings Growth
|
-57.00 |
|
Operating Cash Flow (M)
|
315 |
|
Levered Free Cash Flow (M)
|
187 |
Stock Valuations |
|
PE Ratio
|
70.53 |
|
PEG Ratio
|
|
|
Price to Book value
|
13.20 |
|
Price to Sales
|
16.73 |
|
Price to Cash Flow
|
44.68 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
